Publication | Closed Access

Clinical Protocol: A Phase I Trial of Intra Lesional RV-B7.1 Vaccine in the Treatment of Malignant Melanoma. Albert Einstein Center, Bronx, New York.

VaccinationTumor ImmunologyMedicineMelanomaImmunologyTumor ImmunityVaccine TrialTherapeutic VaccineImmunotherapeuticsClinical ProtocolNew YorkMalignant MelanomaImmunotherapyOncologyRadiation Oncology